Xtep International Holdings Limited (XTEPY) Q2 2026 Earnings Call Prepared Remarks Transcript

Xtep’s Q2 2026 interim results call emphasized a complex/volatile domestic macro backdrop and ongoing industry competition, but highlighted resilient sports consumption with running as a fast-growing subsector. Management cited record registration for major domestic marathons and said Xtep ranked first across multiple major marathons for overall wear rates, supporting its leading position in running.

Analysis

The signal here is not "sportswear is strong"; it is that Xtep may be retaining niche pricing power in performance running while the broader China discretionary backdrop stays soft. That matters only if the brand heat translates into full-price sell-through and lower promo intensity, because marathon wear rates are a vanity metric unless they flow through to ASPs, inventory turns, and gross margin. Relative winners would be Xtep and possibly a small subset of running-focused suppliers; the losers are broader China athleticwear peers that are more exposed to fashion-driven traffic and discounting in the same channels.

Near term, the stock likely reacts better to commentary than to fundamentals, but the real catalyst window is the next 1-3 months when interim numbers show whether the running franchise is incremental or just maintaining share. The key watch items are channel inventory days, wholesale rebate behavior, and whether marketing spend had to rise to defend those marathon placements. If any of those worsen, the market should treat the wear-rate story as marketing noise rather than sustainable revenue quality.

The contrarian view is that the market may be underestimating category resilience but overestimating company-specific monetization. Running can keep growing for 6-18 months, yet that does not guarantee margin expansion if the category remains promotion-heavy or if Xtep has to fund distribution to preserve its lead. Falsifiers are simple: a step-up in inventory, flat-to-down gross margin, or guidance that implies share gains came at the expense of profitability rather than a better mix.

Key Decisions for Investors

• Do not chase XTEPY on the headline alone; wait for the interim filing and management's disclosure on gross margin and inventory turns before initiating a position.
• If H1 data confirm stable-to-improving inventory days and no incremental discounting, consider a small tactical long XTEPY for a 1-3 month trade; upside is driven by rerating on better-quality earnings, not absolute revenue growth.
• Use XTEPY as a relative-value long only if the market is simultaneously rewarding broader China sportswear peers with weaker running exposure; pair trade setup should be long XTEPY vs short a broader China athleticwear proxy such as 2331.HK if their next print shows more promotional pressure.
• Set an alert for any guidance that implies higher promotional spend or worsening channel inventory; that would falsify the thesis and should cap the position quickly.
• If the stock has already rerated into earnings, prefer to stay flat and look for a better entry after the next 1-3 months of sell-through data rather than forcing an options trade in an illiquid name.